Elucidation of osteoporosis prevention mechanism by citrus limonoid by 君羅, 好史
Impact Objectives
• Gain a greater understanding of the potential benefits of the yuzu fruit, particularly  
in relation to bone health 
• Delve deeper into the physiological effects of nomilin, so as to understand the effects  
of the citrus limonoid on other areas of the body 
• Ultimately halt the rise in the number of people suffering from osteoporosis both  
in Japan, where numbers are on the increase, and internationally
Freshly squeezed research
Dr Yoshifumi Kimira is exploring how the humble citrus fruit, with a focus on yuzu, can help improve 
bone health
Could you introduce 
yourself and your 
key research 
interests?
 
I graduated from 
the Department of 
Physical Education, Tokai University, Japan, 
in 2007 and entered the Department of 
Food and Nutrition, Graduate School of 
Agriculture, Tokyo University of Agriculture, 
Japan. I finished my doctoral course in 
2012 and took up the position of research 
assistant at Josai University, Japan. 
Currently, I am Assistant Professor and 
am doing research and education in food 
science. My research subject is the effect of 
collagen-derived peptides or food functional 
factors contained in citrus fruits on bone 
metabolism.
What do you find most interesting about 
your field?
 
I found the idea of studying the functionality 
of foods with an approach that is closer to 
medicine and adopted it. The functional 
ingredients of foods have effects close to 
those of medicines and can be ingested 
from foods, so there is a safety aspect
as well. I believe that by maximising this 
benefit we can propose a meal that will lead 
to disease prevention.
Can you introduce the basis of your 
project ‘Citrus limonoid nomilin inhibits 
osteoclastogenesis in vitro by suppression 
of NFATc1 and MAPK signalling pathways’?
 
Limonoids show various physiological 
effects, but the effect of limonoids on bone 
metabolism remains unknown. We studied 
the major citrus limonoid, nomilin, on 
osteoclast differentiation and activity signal 
transduction.
What are the known benefits of nomilin and 
what led you to question the potential in 
relation to bone health?
 
Limonoid has been reported to have 
antioxidant activity, anti-tumourigenic 
activity and hypoglycaemic effect, and 
improve hyper-lipoedema. Although it 
has already been clarified that fruit has a 
positive effect on bones, there have been 
some reports showing the possibility 
that the limonoids contained in fruit peel 
and seeds can also affect bone. We also 
investigated whether nomilin has an effect 
on bone metabolism.
Are you able to confirm any benefits 
to nomilin, particularly in relation to 
osteoporosis?
 
It has been confirmed that nomilin has 
an action on osteoclast differentiation 
and activity. The results of the animal test 
have not been seen yet, but considering 
there are many targeted osteoclasts in the 
mechanism of action of the therapeutic 
agent for osteoporosis, nomilin is considered 
to be beneficial for the prevention of the 
development of osteoporosis.
At what stage of your research are you at 
and what is the immediate next step?
   
We are still in the first phase of basic 
research and have a way to go. I would like 
to conduct research that can contribute to 
people’s health through the functionality of 
yuzu (a citrus fruit). As an approach to the 
problem of agriculture, I think that we have 
made considerable progress.
How do you see your research progressing 
in the next five to 10 years?
 
The amount of waste yuzu will be reduced, 
and yuzu farmers will be able to produce 
lots of fragrant yuzu abundantly. Also, I 
would like to present research results that
show there are many people who enjoy the 
citrus fruits as food, but at the same time 
are also enjoying the health benefits. O
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Introducing yuzu
A team of researchers based at Josai University, Japan, wants to help improve population bone health  
by introducing a special citrus fruit
You have surely heard of oranges, lemons 
and limes, but what about yuzu? This is 
a citrus fruit originally stemming from 
central China and Tibet, and associated 
with Japanese cuisine. Although it is rarely 
eaten as a fruit, its scented juice and zest 
can be added to sweet and savoury dishes 
to add unique flavour. A team of Japanese 
researchers is exploring the potential of the 
fruit to be used medicinally, with a focus on 
bone health.
Dr Yoshifumi Kimira is part of a research 
team that is investigating how citrus 
fruits could potentially alleviate various 
types of bone disease. He is based in 
the Department of Clinical Dietetics and 
Human Nutrition in the Faculty of Pharmacy 
and Pharmaceutical Sciences at Josai 
University, Japan. He is working alongside 
fellow Josai University researchers, as well 
as collaborators from Liberty House, a food 
processing company, and from Moroyama 
town, Saitama. These collaborations 
were necessary, as Kimira explains: ‘I’m 
not a specialist in food processing, so 
collaborating with companies specialising  
in food processing was very important.’
NATURE’S MEDICINE
The team’s project is entitled ‘Citrus 
limonoid nomilin inhibits osteoclastogenesis 
in vitro by suppression of NFATc1 and 
MAPK signalling pathways’. Liminoids are 
phytochemicals found in citrus fruit, 53 
of which have been identified, including 
the limonoids nomilin and nomilinic acid. 
These have been studied in anti-cancer 
research and now Kimira and his team are 
studying the potential effects of nomilin 
on osteoclastogenesis, which is the 
development of osteoclasts – a type of bone 
cell that breaks down bone tissue – from 
blood cells. Despite nomilin having been 
reported to have many biological activities 
in animal systems, its mechanism on bone 
metabolism is unclear.
Kimira and his team are trying to fill the 
gaps in the research on nomilin and how 
it affects osteoclasts. ‘Although the effect 
of nomilin on the gene expression of 
osteoclasts and the effect on intracellular 
signalling can be seen, we have not been 
able to examine how nomilin exerts 
influence on cells from outside the cell,’ 
Kimira explains. ‘Since nomilin has been 
reported to be a ligand for TGR5, which is a 
bile acid receptor expressed in the intestinal 
tract, if it can be confirmed that TGR5 is 
expressed in osteoclasts, I believe the effect 
of nomilin can be extracellularly considered.’
There are recommendations in place for 
the prevention of osteoporosis in Japan. 
For example, Japan’s 2015 Guidelines for 
Prevention and Treatment of Osteoporosis 
state that in order to prevent the onset of 
the disease, it is recommended that people 
under the age of 18 begin exercising, in 
addition to consuming the right nutrition, 
while those who are middle aged or 
elderly are advised to maintain a ‘healthy’ 
weight, follow nutritional guidelines, 
avoid smoking and perform daily exercise. 
However, despite these recommendations, 
osteoporosis is on the increase in Japan, 
as Kimira explains: ‘The number of 
osteoporosis patients in Japan is 12.8 
million (three million men and 9.8 million 
women). From an international perspective, 
incidence rates have begun to decline, such 
as in Europe, Canada and the US. However, 
in Japan, the number of osteoporosis 
patients is rising and it is considered very 
important to prevent disease onset.’
MYSTERIOUS MECHANISMS
In their current project, the researchers 
are building on existing animal studies 
that have shown a positive correlation 
between intake of citrus fruits and bone 
health. Specifically, their aim is to reveal 
the mechanism of nomilin on osteoclastic 
differentiation of mouse primary bone 
marrow-derived macrophages (BMMs) and 
the mouse RAW 264.7 macrophage cell 
line into osteoclasts. This could shed light 
on the prevention of bone diseases. ‘The 
most common cause of osteoporosis is the 
balance collapse of bone resorption and 
bone formation caused by the reduction  
of oestrogen by menopause. 
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PROJECT COORDINATOR BIO 
Yoshifumi Kimira is an Assistant Professor 
at the Department of Clinical Dietetics 
and Human Nutrition in the Faculty of 
Pharmacy and Pharmaceutical Sciences 
at Josai University, Japan. His research 
focuses on how to prevent skeletal 
diseases by functional food factors 
contained in citrus fruits and to solve the 
problems of disposal in food production 
to reduce the burden of the farmers.
If osteoclast differentiation and activity 
can be kept normal, bone density is 
preserved,’ explains Kimira. ‘We believe that 
nomilin can demonstrate efficacy against 
the onset mechanism of osteoporosis by 
controlling the differentiation and activity of 
osteoclasts.’
To do this, the team is using a cell counting 
kit to measure the cell viability of RAW 
264.7 and BMMs, with TRAP-positive 
multinucleated cells counted as osteoclast 
cell numbers. The number and area of 
resorption pits were measured as bone-
resorbing activity. Osteoclast-specific gene 
expression was evaluated by quantitative 
real-time polymerase chain reaction (PCR); 
and protein expression was evaluated by 
western blot.
The team found that nomilin significantly 
decreased TRAP-positive multinucleated 
cell numbers compared with the control, 
and exhibited no cytotoxicity. In addition, 
nomilin decreased bone resorption activity, 
as well as down regulating osteoclast-
specific genes, NFATc1 and TRAP mRNA 
levels. Furthermore, nomilin suppressed 
MAPK signalling pathways. This led the 
researchers to conclude that nomilin 
has inhibitory effects on osteoclastic 
differentiation in vitro. They believe the 
findings suggest that nomilin-containing 
herbal preparations could potentially be 
utilised in the prevention of bone metabolic 
diseases.
MAGIC PASTE
Kimira believes this can be done in the 
form of a special paste from yuzu, as he 
explains: ‘I believe that by using yuzu paste 
containing high dose nomilin developed 
by us, we can introduce nomilin into our 
diets and reap the benefits.’ Currently, large 
amounts of yuzu go to waste, as the rest 
of the fruit tends to be discarded once the 
juice has been obtained. Kimira and the 
team want to reduce this waste, using the 
fruit’s peel and seeds. ‘Because the use of 
yuzu is mostly squeezing fruit juice and 
grating a small amount of peel for the scent, 
about half the weight of the production is 
discarded. The fee for disposal is seriously 
damaging for yuzu farmers. We have created 
a paste named Tanemadeyuzuran that 
contains yuzu’s fruit, peel and seed, using 
the fruit effectively.’
In the future, the researchers hope that 
the use of yuzu in food will broaden. In 
addition, they believe it would be beneficial 
to collaborate with a group studying the 
physiological effects of nomilin in areas 
other than bone metabolism to further 
develop their research. Ultimately, they are 
en route to helping improve population 
health and, in doing so, reducing the waste 
of a valuable fruit. O
Nomilin can demonstrate efficacy against the 
onset mechanism of osteoporosis by controlling  
the differentiation and activity of osteoclasts
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